Results 221 to 230 of about 75,315 (267)

Autologous stem cell transplantation and IgM amyloidosis

Leukemia & Lymphoma, 2006
High dose chemotherapy (HDC) followed by autologous stem cell transplant (ASCT) is an accepted form of treatment for patients with AL amyloidosis. The purpose of the current study is to review the outcomes of IgM AL amyloidosis patients treated with high dose chemotherapy and autologous stem cell transplant and compare them to the outcomes of all AL ...
Maria, Valente, Vivek, Roy, Martha Q, Lacy, Angela, Dispenzieri, Morie A, Gertz   +4 more
openaire   +2 more sources

Autologous Stem Cell Transplantation

2016
Autologous stem cell transplantation (ASCT) is a treatment strategy that allows for the administration of higher than usual doses of myelotoxic chemotherapy and/or radiation therapy to treat several hematologic and nonhematologic malignancies. High-dose chemotherapy (HDT) with ASCT is widely performed in HIV-negative patients with Hodgkin (HL) and non ...
Alessandro Re, Amrita Krishnan, Marcus Hentrich   +2 more
openaire   +1 more source

Autologous stem cell transplantation for myocardial repair

American Journal of Physiology-Heart and Circulatory Physiology, 2004
Current therapies for heart failure due to transmural left ventricular (LV) infarction are limited. We have developed a novel patch method for delivering autologous bone marrow stem cells to sites of myocardial infarction for the purpose of improving LV function and preventing LV aneurysm formation.
Jingbo, Liu, Qingsong, Hu, Zongli, Wang, Chengsu, Xu, Xiaohong, Wang, Guangrong, Gong, Abdul, Mansoor, Joseph, Lee, Mingxiao, Hou, Lepeng, Zeng, John R, Zhang, Michael, Jerosch-Herold, Tao, Guo, Robert J, Bache, Jianyi, Zhang   +14 more
openaire   +2 more sources

Autologous Stem Cell Transplantation in Myelodysplastic Syndromes

Seminars in Hematology, 2007
Allogeneic stem cell transplantation (SCT) is the treatment of choice for the majority of young patients with myelodysplasia (MDS) who have a histocompatible donor (sibling or unrelated donor). For some patients lacking a human leukocyte antigen (HLA)-compatible donor, chemotherapy followed by autologous SCT may be a reasonable alternative, especially ...
Witte, T.J.M. de, Suciu, S., Brand, R., Muus, P., Kroger, N.   +4 more
openaire   +3 more sources

Rationale for Purging in Autologous Stem Cell Transplantation

Journal of Hematotherapy, 1993
The success of autologous stem cell transplantation using bone marrow or peripheral blood stem cells depends not only on in vivo irradication of the disease by cytotoxic therapy but also on complete hematopoietic engraftment with no risk of relapse from the infused cells. Various methods are available for removing (purging) such contaminants.
S C, Gulati, L, Acaba
openaire   +2 more sources

Complications of autologous hematopoietic stem cell transplantation

Haematologia, 2000
Myeloablative therapy followed by autologous hematopoietic stem cell (HSC) transplantation is a therapeutic option proposed for a variety of hematological and non-hematological diseases. However, although mortality due to this procedure is steadily decreasing, patients are still exposed to the risk of a number of complications negatively affecting ...
G, Lambertenghi Deliliers, C, Annaloro, D, Lambertenghi Deliliers   +2 more
openaire   +2 more sources

Autologous transplantation with circulating hemopoietic stem cells

Journal of Clinical Apheresis, 1987
AbstractCirculating stem cells exist in sufficient numbers in mouse, dog, and man to allow collection and transplantation after ablative treatment. Preclinical studies in the mouse have shown a low concentration, with a transplantation potential ratio of bone marrow to blood of 1:100.
A R, Zander, K J, Cockerill
openaire   +2 more sources

Autologous Stem Cell Transplantation in Autoimmune Diseases

Seminars in Hematology, 2007
Since 1996, approximately 1,000 patients have received an autologous hematopoietic stem cell transplant (HSCT) as treatment for a severe autoimmune disease (AD). The European Group for Blood and Marrow Transplantation (EBMT)/European League Against Rheumatism (EULAR) Autoimmune Disease Working Party have registered more than 800 patients and works in ...
Passweg J, Tyndall A
openaire   +3 more sources

Autologous hematopoietic stem cells transplantation in MOGAD

Multiple Sclerosis Journal
[no abstract available]
Mariotto, Sara, Carta, Sara
openaire   +3 more sources

Upfront Tandem Autologous Stem Cell Transplant Is Superior to Autologous or Allogeneic Stem Cell Transplant After Failure of a 1st Autologous Transplant,

Blood, 2011
Abstract Abstract 4094 Disease progression remains the main cause of treatment failure after autologous stem cell transplant (SCT) in patients with multiple myeloma (MM). It is unclear what is the best salvage therapy after failure of a 1st autologous SCT in MM.
Adrian Wong, Charles F. LeMaistre, Paul Shaughnessy, Carlos Bachier   +3 more
openaire   +1 more source